Original ArticlesMacular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study
Section snippets
Patients and methods
Patients examined at The Cole Eye Institute of the Cleveland Clinic Foundation were eligible to participate in the study if they met the following inclusion criteria: (1) age 60 years or older, (2) best-corrected visual acuity between 20/50 and 20/800 in the eligible eye, (3) evidence of drusen in both eyes, and (4) age-related macular degeneration with new or recurrent choroidal neovascularization that involved the geometric center of the foveal avascular zone and that measured 6 Macular
Results
Of the 10 patients, five were men and five were women (Table 1). Their ages ranged from 66 to 86 years (median, 77 years). The patients were referred for treatment of choroidal neovascularization from age-related macular degeneration and had a history of blurred vision or metamorphopsia in the affected eye for 7 to 365 days (median, 111 days). The operated-on eye was the right eye in six patients and the left eye in four patients. The fellow eye showed drusen in 10 patients, geographic atrophy
Discussion
Age-related macular degeneration is the leading cause of irreversible visual loss in the western hemisphere. Approximately 10% to 20% of patients with age-related macular degeneration develop the exudative form of the disease, characterized by choroidal neovascularization.12, 13 It is estimated that in the United States, 100,000 to 200,000 people develop choroidal neovascularization every year.14 Currently, the only beneficial treatment for choroidal neovascularization is photocoagulation, as
References (25)
- et al.
Translocation of the retina for subfoveal choroidal neovascularization, Iexperimental studies in the rabbit eye
Am J Ophthalmol
(1998) - et al.
Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes
Am J Ophthalmol
(1996) - et al.
Translocation of the retina for management of subfoveal choroidal neovascularization, IIa preliminary report in humans
Am J Ophthalmol
(1998) - et al.
Visual function after foveal translocation with scleral shortening in patients with myopic neovascular maculopathy
Am J Ophthalmol
(1998) - et al.
External beam radiation therapy for choroidal neovascularization
Ophthalmology
(1998) - et al.
Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes
Am J Ophthalmol
(1998) - et al.
Exudative age-related macular degeneration
Laser photocoagulation of subfoveal neovascular lesions of age-related macular degenerationupdated findings from two clinical trials
Arch Ophthalmol
(1993)Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degenerationresults of a randomized clinical trial
Arch Ophthalmol
(1991)- et al.
Experimental retinal relocation
Invest Ophthalmol Vis Sci
(1983)
Surgical relocation of the macula
Invest Ophthalmol Vis Sci
Retinal separation, retinotomy and macular relocation, Iexperimental studies in rabbit eye
Graefes Arch Clin Exp Ophthalmol
Cited by (127)
Retinotomies and retinectomies: A review of indications, techniques, results, and complications
2023, Survey of OphthalmologyLong-term effect of intravitreal aflibercept treatment on choroidal vascularity index in neovascular age-related macular degeneration
2021, Photodiagnosis and Photodynamic TherapyLongitudinal study of macular folds by spectral-domain optical coherence tomography
2012, American Journal of OphthalmologyChoroidal neovascularization in pathological myopia
2012, Progress in Retinal and Eye ResearchMacular translocation
2012, Retina Fifth EditionLongitudinal study of macular folds by spectral-domain optical coherence tomography
2012, American Journal of Ophthalmology